Silexion Therapeutics Corp. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1294204,
    "name": "Silexion Therapeutics Corp.",
    "stock_name": "Silexion Therapeutics Corp.",
    "full_name": "Silexion Therapeutics Corp.",
    "name_url": "stocks-analysis/silexion-therapeutics-corp",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "3.02",
    "chg": -0.12,
    "chgp": "-3.82%",
    "dir": -1,
    "prev_price": "3.14",
    "mcapval": "5.19",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "KYG1281K1307",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "16.73 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/silexion-therapeutics-corp-1294204-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Silexion Therapeutics Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-silexion-therapeutics-corp-technically-bullish-or-bearish-3549139",
        "imagepath": "",
        "date": "2025-09-20 20:33:41",
        "description": "As of 1 October 2023, the technical stance for Silexion Therapeutics Corp. is bearish, with overall weakness indicated by multiple metrics. The MACD shows a mildly bullish signal on both weekly and monthly time frames, while the RSI is bullish in the same periods. However, the Bollinger Bands, KST, and Dow Theory all indicate bearish trends on both weekly and monthly levels. The daily moving averages are also bearish. \n\nThe stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -88.03% versus the S&P 500's 12.22%, highlighting a stark contrast in performance...."
      },
      {
        "title": "Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.37",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/silexion-therapeutics-corp-stock-plummets-to-new-52-week-low-of-337-3531602",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SilexionTherape_priceRelatedfactors_3531602.png",
        "date": "2025-09-18 13:31:46",
        "description": "Silexion Therapeutics Corp. has reached a new 52-week low, reflecting significant volatility in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 5 million, the company faces operational challenges, evidenced by a low return on equity and a lack of dividends, amid a contrasting performance compared to the S&P 500."
      },
      {
        "title": "Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.44",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/silexion-therapeutics-corp-stock-plummets-to-new-52-week-low-of-344-3525982",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SilexionTherape_priceRelatedfactors_3525982.png",
        "date": "2025-09-17 15:27:25",
        "description": "Silexion Therapeutics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance compared to the S&P 500. With a market capitalization of USD 5 million, the company faces challenges indicated by its high price-to-book ratio and negative return on equity, raising questions about its future strategies."
      },
      {
        "title": "Silexion Therapeutics Corp. Stock Hits New 52-Week Low at $3.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/silexion-therapeutics-corp-stock-hits-new-52-week-low-at-355-3519706",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/SilexionTherape_priceRelatedfactors_3519706.png",
        "date": "2025-09-16 11:38:51",
        "description": "Silexion Therapeutics Corp. has reached a new 52-week low, emphasizing its stock volatility compared to a much higher peak. With a market capitalization of USD 5 million, the company faces financial challenges, including a negative return on equity and no dividend issuance, amid broader biotechnology sector trends."
      }
    ],
    "total": 4,
    "sid": "1294204",
    "stock_news_url": "https://www.marketsmojo.com/news/silexion-therapeutics-corp-1294204"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Silexion Therapeutics Corp. technically bullish or bearish?

2025-09-20 20:33:41

As of 1 October 2023, the technical stance for Silexion Therapeutics Corp. is bearish, with overall weakness indicated by multiple metrics. The MACD shows a mildly bullish signal on both weekly and monthly time frames, while the RSI is bullish in the same periods. However, the Bollinger Bands, KST, and Dow Theory all indicate bearish trends on both weekly and monthly levels. The daily moving averages are also bearish. The stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -88.03% versus the S&P 500's 12.22%, highlighting a stark contrast in performance....

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.37

2025-09-18 13:31:46

Silexion Therapeutics Corp. has reached a new 52-week low, reflecting significant volatility in the pharmaceuticals and biotechnology sector. With a market capitalization of USD 5 million, the company faces operational challenges, evidenced by a low return on equity and a lack of dividends, amid a contrasting performance compared to the S&P 500.

Silexion Therapeutics Corp. Stock Plummets to New 52-Week Low of $3.44

2025-09-17 15:27:25

Silexion Therapeutics Corp. has reached a new 52-week low, reflecting a significant decline in its stock performance compared to the S&P 500. With a market capitalization of USD 5 million, the company faces challenges indicated by its high price-to-book ratio and negative return on equity, raising questions about its future strategies.

Silexion Therapeutics Corp. Stock Hits New 52-Week Low at $3.55

2025-09-16 11:38:51

Silexion Therapeutics Corp. has reached a new 52-week low, emphasizing its stock volatility compared to a much higher peak. With a market capitalization of USD 5 million, the company faces financial challenges, including a negative return on equity and no dividend issuance, amid broader biotechnology sector trends.

View All News